Newsletters - June 1997

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Sabinsa recently announced the introduction of a unique, new process for the manufacture of Glucosamine Sulfate. This new process incorporates the use of potassium rather than sodium as a bonding agent, creating a safer, higher quality product with increased absorption.

Demographically speaking, the most common use of Glucosamine Sulfate in conjunction with symptoms of arthritis is found among senior citizens. Consistent use of a sodium based product poses an additional risk for those already concerned about their daily intake of sodium.

Sabinsa's new patent-pending process for a potassium based product eliminates the risk of increased sodium intake and provides a high quality alternative with increased absorption characteristics.


  • Sabinsa Corporation
    20 Lake Drive
    East Windsor
    NJ 08520, USA

  • +1 732 777 1111
  • +1 732 777 1443


Certificate Logos Certificate Logos Certificate Logos Certificate Logos